a clinical-stage biotechnology company, which engages in the discovery and development of engineered T cell therapies for B cell-mediated autoimmune diseases
Industry Biotechnology
A.I.dvisor indicates that over the last year, CABA has been loosely correlated with RCKT. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if CABA jumps, then RCKT could also see price increases.
Ticker / NAME | Correlation To CABA | 1D Price Change % | ||
---|---|---|---|---|
CABA | 100% | N/A | ||
RCKT - CABA | 39% Loosely correlated | +10.32% | ||
PLRX - CABA | 39% Loosely correlated | +1.01% | ||
SLRN - CABA | 37% Loosely correlated | +8.55% | ||
PRME - CABA | 37% Loosely correlated | +7.74% | ||
ALLO - CABA | 37% Loosely correlated | +4.74% | ||
More |